• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Next Generation Sequencing Report 2013 - Product Image

Next Generation Sequencing Report 2013

  • ID: 2668553
  • September 2013
  • Region: Global
  • 136 Pages
  • Yole Développement


  • 23andme
  • Base 4
  • Completegenomics
  • Genia Technologies
  • Illumina
  • Noblegen Biosciences
  • MORE

NGS technologies drive the way toward personalized medicine

NGS technologies have demonstrated the capacity to sequence DNA at unprecedented speed, enabling previously unimaginable novel healthcare applications. By providing valuable data on patient genomes, NGS technologies are filling the gap separating traditional and personalized medicine. Along with a global shift toward personalized medicine and through the development of advanced bioinformatic tools, NGS technologies will have a striking impact on cancer management, treatments of rare diseases and future developments of genetic therapies.

The change will be gradual, starting with oncology where personalized medicine is more likely to be accepted. Physicians will have to change their way of working to take full advantage of this giant leap forward in medicine. To do so, medical school coursework will likely evolve in the near future to integrate how to work with genomics data.

The Next Generation Sequencing market is poised to reach $4.4B in 2018!

Starting its transition from research to clinical market, the Next Generation Sequencing (NGS) market will sharply grow from $2.2B to $4.4B in 2018.



  • 23andme
  • Base 4
  • Completegenomics
  • Genia Technologies
  • Illumina
  • Noblegen Biosciences
  • MORE

1. Executive summary

2. Introduction

3. Market data
- Global Next Generation Sequencing market in $M 2013-2018
- Next Generation Sequencing equipment market, in units, $M 2013-2018
- Next Generation Sequencing consumable market, in units, $M 2013-2018

4. Market segmentation

5. Next Generation Sequencing technologies overview
- From biotechnology point of view
- From cartridge point of view

6. Value chain and supply chain

7. Market trends and challenges

8. Company profiles

· Summary and conclusions (p.136)

- 23andme
- Affymetrix
- Azco Biotech Inc
- Baseclear
- Base 4
- BGI-Shenzhen
- Completegenomics
- DNAvision
- Genia Technologies
- Genapsys
- GnuBIO
- Hitachi
- Illumina
- LaserGen
- NabSys
- Noblegen Biosciences
- Oxford Nanopore Technologies
- Pacific Biosciences
- Qiagen
- Roche 454
- Stratos Genomics Inc.
- Thermo Fisher Scientific

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos